RADIANCE – Radiochemotherapy with or without Durvalumab in the treatment of anal squamous cell carcinoma: A randomized multicenter phase II trial
Daniel Martin(Goethe University Frankfurt), Emmanouil Fokas(Düsseldorf University Hospital), Christian Weiß(University of Bern), Johannes Gollrad(Charité - Universitätsmedizin Berlin), Bülent Polat(University of Würzburg), Claus Belka(LMU Klinikum), Cihan Gani(German Cancer Research Center), David Krug(University Hospital Schleswig-Holstein), Panagiotis Balermpas(University of Zurich), Stephanie E. Combs(Helmholtz Zentrum München), Tilman Bostel(Johannes Gutenberg University Mainz), Henning Schäfer(University Medical Center Freiburg), Thomas Kuhnt(Leipzig University), Martin Stuschke(Essen University Hospital), Matthias Hautmann, Jürgen Debus(Heidelberg University), Guido Hildebrandt(University of Rostock), Thomas Brunner(Medical University of Graz), Ursula Nestle(University Medical Center Freiburg), Rita Engenhart‐Cabillic(Philipps University of Marburg), Christoph Henkenberens, Chiara Valentini(University Hospital Carl Gustav Carus), Claus Rödel(Goethe University Frankfurt)
Cited by 33
Related Papers
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer
|Annals of Oncology|2021|1.4k
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2023|830
Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2023|782